The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Sachdeva
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE has received a disclosure under Regulation 29(1) & 29(2) of SEBI's Substantial Acquisition of Shares & Takeovers Regulations, 2011, filed by Sunil Sachdeva in relation to Global Health Ltd. This type of filing is required when a shareholder crosses or intends to cross prescribed shareholding thresholds. The specific direction of the transaction (acquisition or disposal) and the percentage involved are not mentioned in the headline. Investors should refer to the full disclosure on the BSE website for details on whether shares were bought or sold.
This is a routine regulatory disclosure and by itself does not indicate a major shift in ownership. Shareholders should check the full filing to understand whether the move is a buy or sell, the size of the change, and whether any open-offer trigger is involved.